^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Alecsat (cytotoxic lymphocyte-based cancer vaccine)

    i
    Other names: cytotoxic lymphocyte-based cancer vaccine
    Associations

    News

    Trials
    Company:
    CytoVac
    Drug class:
    NK cell stimulant, Cytotoxic T lymphocyte stimulant
    Related drugs:
    Associations

    News

    Trials
    4years
    ImmunoBreast - A Phase Ib Study (clinicaltrials.gov)
    P1/2, N=20, Recruiting, Henrik Ditzel
    Clinical • New P1/2 trial
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
    |
    HER-2 positive • HR positive • ER expression
    |
    carboplatin • gemcitabine • Alecsat (cytotoxic lymphocyte-based cancer vaccine)